scroll
LEARN MORE
14 DAYS FREE ACCESS
Join Market Matters and get full access
to all our Opinion + Action
ASX.RMD $24.34
20 MINUTE DELAYED
ANALYSIS
OPINION
ACTION
more
i
PERFORMANCE
i
SHARE PRICE ACTIVITY | |
---|---|
Last (Price) | 24.34 |
Change | 0.00 (0.00) |
Bid / Ask | 24.80 - 23.71 |
Volume | 0 |
Volume (3mths avg) | 0 |
Turnover | 0 |
Open | 0.00 |
Day Range | 24.07 - 24.38 |
VWAP | 0.00 |
Prev Close | 24.34 |
Last Trade | 01/12 7:45am (AEST) |
i
KEY INFORMATION | |
---|---|
Sector | |
Shares Issued | |
NTA/Share | 0.00 |
Last Dividend | 0.05 |
Dividend Ex Date | 08 NOV 2023 |
Dividend Pay Date | 14 DEC 2023 |
i
CURRENT () | |
---|---|
Revenue | 3,578.13 |
EBITDA | 1,161.76 |
Profit | 850.77 |
Earnings Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0 |
Yield % | 0.80 |
Market Cap | 0 |
Price to Earnings Ratio (P/E) | 26.39 |
i
TARGET PRICE FORECAST
i
ESTIMATES () | |
---|---|
Revenue | 4,629.36 |
EBITDA | 1,517.12 |
Profit | 1,063.46 |
Earnings Per Share (EPS) | 0.73 |
Dividend Per Share (DPS) | 0.20 |
i
BROKER CONSENSUS RECOMMENDATION
BUY
SELL
Target Price
0.00
Lt Growth Rate
0.00
Recommendation (BUY)
1.83
ACTION
RMD
UPDATED
07/11/2023 08:52
MM remains long and cautiously bullish toward RMD
Add To Hit List
RMD
UPDATED
16/10/2023 15:40
RMD
UPDATED
13/09/2023 09:35
RMD
UPDATED
31/08/2023 10:15
RMD
UPDATED
23/08/2023 08:37
RMD
UPDATED
18/08/2023 08:26
MM remains long and bullish toward ResMed Inc (RMD)
Add To Hit List
RMD
UPDATED
11/08/2023 10:04
RMD
UPDATED
11/08/2023 09:40
MM are adding to RMD in the Flagship Growth Portfolio, increasing to a 5% target weighting around $27.50
Add To Hit List
RMD
UPDATED
08/08/2023 16:30
RMD
UPDATED
04/08/2023 16:19
MM is now neutral RMD following todays result
Add To Hit List
Business Summary
ResMed (RMD) develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.Relevant suggested news and content from the site
Only available to Members
Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing.
Click here